Patent ID: 11873532
Assignee: 2. THE REGENTS OF THE UNIVERSITY OF MICHIGAN
Field: Measurement (Instruments)
Classification: CPC C  G | IPC C  G

Claim 1:
2. A method comprising:
a) selecting a subject with prostate cancer having a luminal B subtype, wherein the subtype is determined according to a genomic subtyping classifier based on the presence or expression levels in a biological sample from the subject of targets CDC20, KIF2C, PHGDH, NUF2, CENPF, EXO1, UBE2T, RRM2, MLPH, GPR160, CCNB1, CXXC5, PTTG1, FGFR4, FOXC1, ESR1, ANLN, BLVRA, EGFR, ACTR3B, NAT1, MYC, SFRP1, MELK, BAG1, CEP55, MKI67, TMEM45B, PGR, MDM2, KRT5, FOXA1, ORC6, CDH3, ERBB2, GRB7, CDC6, MAPT, BIRC5, KRT14, KRT17, TYMS, NDC80, SLC39A6, BCL2, CCNE1, MIA, MYBL2, UBE2C, and MMP11; and
b) treating the subject with a treatment comprising androgen deprivation therapy.